Drug intelligence / Profile preview

alcohol + cocaine

Development stage
Discontinued
Lead developer
Tempero Bio
Modality
Small Molecules
Administration
Oral, Intranasal, Inhalation, Intravenous
01

Overview

Alcohol + cocaine refers to the concurrent use of ethanol (alcohol) and cocaine. When these substances are used together, the liver metabolizes them into a unique psychoactive compound called cocaethylene. Cocaethylene has similar stimulant properties to cocaine but is more cardiotoxic and has a longer half-life, leading to prolonged and intensified psychoactive effects compared to either drug alone[1][2][3]. The combination increases dopamine and serotonin levels by blocking their reuptake in the brain, which enhances euphoria but also raises risks for impulsivity, aggression, anxiety, depression, heart attack, stroke, seizures, liver damage, and sudden death[1][2][3][4]. The combined use is associated with higher rates of polysubstance abuse disorders and significantly greater risk of overdose or fatal cardiovascular events than using either substance alone[2][5]. There are no pharmaceutical developers or manufacturers for this combination; it arises from recreational or illicit co-use.

Other names
cocaethylene precursorconcurrent alcohol and cocaine useethanol + cocaine
02

Targets

DAT (Dopamine plasma membrane transport protein)δ-GABAAR (Extrasynaptic GABA-A receptor delta-containing subtype)NMDAR (Glutamate receptor ionotropic, NMDA)NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on alcohol + cocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alcohol + cocaine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call